OVERVIEW

Employing Urine Drug Testing to Optimize Patient Outcomes in Chronic Opioid Use is organized by Pri-Med and will be held from Oct 24, 2018 - Oct 24, 2019. This CME Conference has been approved for a maximum of 0.50 AMA PRA Category 1 Credits.

Overview :
The routine use of UDT according to current prescription drug monitoring guidelines allows for a comprehensive assessment of opioid misuse grounded in policy rather than decisions based on individual patient characteristics, decreasing the stigma that can be associated with this type of testing.

Learning Objectives :
• Appreciate the benefit of standardized UDT and implement current prescription drug monitoring guidelines into clinical practice to ensure maximal therapeutic effect, while mitigating opioid misuse, abuse, accidental overdose, and death

Additional details will be posted as soon as they are available.